Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001062993-22-001688
Filing Date
2022-01-27
Accepted
2022-01-27 16:50:48
Documents
1
Period of Report
2022-01-25

Document Format Files

Seq Description Document Type Size
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.html 4  
1 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES form4.xml 4 3752
  Complete submission text file 0001062993-22-001688.txt   5176
Mailing Address TWO CORPORATE DRIVE C/O FIVE PRIME THERAPEUTICS, INC. SOUTH SAN FRANCISCO CA 94080
Business Address
Borges Luis (Reporting) CIK: 0001684015 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40498 | Film No.: 22563824

Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Issuer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)